HealthcareMachine Learning4 min reading time

Man Announces That He Has Synthesized a New Schizophrenia Treatment in His Garage, Based on a Formula Devised by ChatGPT

Futurism
Read full post
Douglas Yao, a biochemist working independently in his garage, has synthesized a new schizophrenia drug called PAC-3310, designed with ChatGPT's help. He claims it improves on the recently approved antipsychotic Cobenfy and is testing it in cell lines and mice, aiming to reduce drug development costs significantly.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News
Healthcare5 min read

​Digital Finance Needs A New Kind Of Identity For AI-Driven Economies

Forbes